Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
Sci Rep
.
2016 Jul 7:6:28124.
doi: 10.1038/srep28124.
Authors
Linda A Gallo
,
Micheal S Ward
,
Amelia K Fotheringham
,
Aowen Zhuang
,
Danielle J Borg
,
Nicole B Flemming
,
Ben M Harvie
,
Toni L Kinneally
,
Shang-Ming Yeh
,
Domenica A McCarthy
,
Hermann Koepsell
,
Volker Vallon
,
Carol Pollock
,
Usha Panchapakesan
,
Josephine M Forbes
PMID:
27389496
PMCID:
PMC4936511
DOI:
10.1038/srep28124
No abstract available
Publication types
Published Erratum